AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 108 filers reported holding AVROBIO INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $6,288,000 | -64.0% | 1,633,333 | -47.9% | 0.22% | -59.9% |
| Q3 2021 | $17,484,000 | -37.2% | 3,133,333 | 0.0% | 0.54% | -42.7% |
| Q2 2021 | $27,855,000 | -29.9% | 3,133,333 | 0.0% | 0.94% | -31.2% |
| Q1 2021 | $39,762,000 | -9.0% | 3,133,333 | 0.0% | 1.36% | -11.0% |
| Q4 2020 | $43,679,000 | -6.8% | 3,133,333 | -13.0% | 1.53% | +24.0% |
| Q3 2020 | $46,872,000 | +99.0% | 3,600,000 | +166.7% | 1.24% | -8.3% |
| Q2 2020 | $23,558,000 | +12.1% | 1,350,000 | 0.0% | 1.35% | +7.5% |
| Q1 2020 | $21,006,000 | +73.9% | 1,350,000 | +125.0% | 1.25% | +103.9% |
| Q4 2019 | $12,078,000 | +71.1% | 600,000 | +20.0% | 0.62% | +65.8% |
| Q3 2019 | $7,060,000 | – | 500,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |